0001104659-21-116446.txt : 20210916
0001104659-21-116446.hdr.sgml : 20210916
20210916171539
ACCESSION NUMBER: 0001104659-21-116446
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210914
FILED AS OF DATE: 20210916
DATE AS OF CHANGE: 20210916
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morgan Travis A
CENTRAL INDEX KEY: 0001880403
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40788
FILM NUMBER: 211258618
MAIL ADDRESS:
STREET 1: 8 THE GREEN
STREET 2: SUITE #12081
CITY: DOVER
STATE: DE
ZIP: 19901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Future Health ESG Corp.
CENTRAL INDEX KEY: 0001851182
STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770]
IRS NUMBER: 862305680
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8 THE GREEN
STREET 2: SUITE # 12081
CITY: DOVER
STATE: DE
ZIP: 19901
BUSINESS PHONE: 833-388-8734
MAIL ADDRESS:
STREET 1: 8 THE GREEN
STREET 2: SUITE # 12081
CITY: DOVER
STATE: DE
ZIP: 19901
4
1
tm2127753-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-09-14
0
0001851182
Future Health ESG Corp.
FHLT
0001880403
Morgan Travis A
C/O FUTURE HEALTH ESG CORP.
8 THE GREEN, SUITE #12081
DOVER
DE
19901
1
1
1
0
Chief Financial Officer
Common stock, par value $0.0001 per share
2021-09-14
4
S
0
614900
0.01
D
103850
I
See Footnote
Common stock, par value $0.0001 per share
562781
I
See Footnote
Common stock, par value $0.0001 per share
2587
I
See Footnote
Common stock, par value $0.0001 per share
129514
I
See Footnote
Warrant
2021-09-14
4
P
0
273507
1.00
A
See Footnote
273507
I
See Footnote
Represents shares transferred by MB Equity, LLC to anchor investors in connection with the Issuer's initial public offering at the same price per share as MB Equity, LLC initially paid for such shares.
Includes up to 13,546 shares subject to forfeiture by MB Equity, LLC if the underwriters in the Issuer's initial public offering do not exercise the over-allotment option in full.
The shares are held directly by MB Equity, LLC. The Reporting Person disclaims beneficial ownership of the securities held by MB Equity, LLC other than the reported securities except to the extent of his pecuniary interest therein.
Includes up to 73,406 shares subject to forfeiture by m2 Enterprises Holdings, LLC if the underwriters in the Issuer's initial public offering do not exercise the over-allotment option in full.
The shares are held directly by m2 Enterprises Holdings, LLC, of which the Reporting Person is the sole manager.
Includes up to 337 shares subject to forfeiture by hc1.com, Inc. if the underwriters in the Issuer's initial public offering do not exercise the over-allotment option in full.
The shares are held directly by hc1.com, Inc. The Reporting Person disclaims beneficial ownership of the securities held by hc1.com, Inc. other than the reported securities except to the extent of his pecuniary interest therein.
Includes up to 16,893 shares subject to forfeiture by Future Health ESG Associates 1, LLC if the underwriters in the Issuer's initial public offering do not exercise the over-allotment option in full.
The securities are held directly by Future Health ESG Associates 1, LLC, of which the Reporting Person is a manager, and indirectly by m2 Enterprises Holdings, LLC, an individual retirement account (IRA) in the name of the Reporting Person, and an IRA in the name of the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. The Reporting Person disclaims beneficial ownership of the securities held by Future Health ESG Associates 1, LLC other than the reported securities except to the extent of his pecuniary interest therein.
Each warrant will become exercisable 30 days after the completion of the Issuer's initial business combination. Each warrant will expire five years after the completion of the Issuer's initial business combination. Each warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustment in the event of certain capital-raising or reorganization transactions.
/s/ Travis A. Morgan
2021-09-15